Discontinued — last reported Q4 '25
STERIS Share Buybacks decreased by 50.1% to $50.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 50.1%, from $100.50M to $50.10M. Over 3 years (FY 2022 to FY 2025), Share Buybacks shows an upward trend with a 55.9% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.67M | $14.08M | $2.88M | $28.15M | $24.68M | $45.24M | $84.03M | $154.61M | $8.72M | $489.00K | $2.23M | $325.00K | $64.20M | $46.42M | $100.50M | $221.00K | $10.60M | $100.50M | $50.10M |
| QoQ Change | — | +32.0% | -79.6% | +878.4% | -12.3% | +83.3% | +85.7% | +84.0% | -94.4% | -94.4% | +355.6% | -85.4% | >999% | -27.7% | +116.5% | -99.8% | >999% | +848.1% | -50.1% |
| YoY Change | — | — | — | — | +131.3% | +221.3% | >999% | +449.3% | -64.7% | -98.9% | -97.3% | -99.8% | +635.9% | >999% | >999% | -32.0% | -83.5% | +116.5% | -50.1% |